
|Articles|August 15, 2003
FDA studies epikeratome refractive surgery device
Atlanta-The FDA is reviewing a pre-market notification from CIBA Vision Corp. for an epikeratome device for use in sub-epithelial separation.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
2
AAO 2025: Advancements in laser refractive surgery
3
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
4
From then to next: Five decades of transformation in ophthalmology
5


















































.png)


